-

Molecular Instruments Launches HCR™ Pro RNA-ISH for Manual Workflows, Enabling Extreme-Sensitivity RNA Imaging in an Accessible Format

LOS ANGELES--(BUSINESS WIRE)--Molecular Instruments® (MI), inventor of the HCR™ technology, today announces the launch of HCR™ Pro RNA-ISH for manual workflows, expanding the unmatched performance and versatility of the HCR™ imaging platform by enabling extreme-sensitivity RNA imaging with chromogenic or fluorescent staining in an accessible and flexible format tailored for hands-on research applications.

HCR™ Pro RNA-ISH enables extreme-sensitivity RNA imaging with chromogenic or fluorescent staining in an accessible and flexible format.

Share

HCR™ Pro RNA-ISH integrates enzymatic signal amplification to enable extreme-sensitivity RNA imaging for the most demanding targets/samples when signal-to-background is at an absolute premium. For example, the assay facilitates rapid scanning of a low-expression target in a highly-autofluorescent sample over a large field-of-view at low magnification.

“HCR™ products are known for redefining what’s possible for RNA imaging in challenging contexts,” said Cameron Earl, Director of Product Management at Molecular Instruments. “HCR™ Pro has already elevated that standard on the leading automated platforms. Now we’re excited to offer the extreme sensitivity of HCR™ Pro RNA-ISH to researchers using manual assays on the full gamut of sample types from whole-mount embryos to ultrathick brain slices.”

HCR™ Pro RNA-ISH pioneers entirely protease-free workflows in tissue sections, preserving sample morphology and maintaining protein target integrity, enabling seamless compatibility with existing immunohistochemistry (IHC)/immunofluorescence (IF) assays.

The assay employs HCR™ HiFi Probes available from MI’s Infinite Catalog for any target RNA in any organism across the tree of life with no design fee and backed by the HCR™ HiFi Probe Promise. Chromogenic staining offers the convenience of brightfield microscopy and the option of archival staining. Fluorescent staining offers the convenience of spectrally distinct channels for multiplex RNA-FISH/IF workflows.

Learn more about manual HCR™ Pro RNA-ISH.

About Molecular Instruments

Molecular Instruments® (www.molecularinstruments.com) develops and synthesizes molecular kits powered by the breakthrough HCR™ imaging platform for applications in academic research, drug development, synthetic biology, and clinical pathology and diagnostics.

Contacts

Media Contact:
Joyce Yoo
Associate Director of Marketing
joyce@molecularinstruments.com

Molecular Instruments

Details
Headquarters: Los Angeles, California
CEO: Harry Choi
Employees: 21-50
Organization: PRI

Release Summary
Molecular Instruments® launches HCR™ Pro RNA-ISH for manual workflows, enabling extreme-sensitivity RNA imaging with chromogenic/fluorescent staining.
Release Versions

Contacts

Media Contact:
Joyce Yoo
Associate Director of Marketing
joyce@molecularinstruments.com

Social Media Profiles
More News From Molecular Instruments

Molecular Instruments® Continues RNA Imaging Leadership with Next-Generation miRNA/siRNA Detection and Clinical-Grade Ready-to-Use Kits

LOS ANGELES--(BUSINESS WIRE)--Molecular Instruments® (MI), the inventor of the HCR™ platform, today announced key enhancements to its HCR™ Gold and HCR™ Pro product lines. These upgrades include next-generation chemistry for high-specificity detection of small RNA targets—including microRNAs (miRNAs) and small interfering RNAs (siRNAs)—and the introduction of a new ready-to-use, prefilled dispenser format for automated assay workflows. Together, these advances represent a pivotal development in...

Molecular Instruments Launches the HCR™ Gold and HCR™ Pro Product Lines to Significantly Expand the HCR™ Imaging Platform

LOS ANGELES--(BUSINESS WIRE)--Molecular Instruments® (MI), founded by the inventor of the HCR™ technology, today announces the launch of the HCR™ Gold and HCR™ Pro product lines. These offerings significantly expand the HCR™ imaging platform to facilitate academic research and biopharma drug development using either manual or automated workflows. The expanded platform supports fluorescent and chromogenic assays for simultaneous RNA and protein imaging with well-preserved sample morphology. HCR™...

Leica Biosystems Announces Partnership With Molecular Instruments As HCR™ Pro RNA-ISH Technology Is Released On The BOND RX and BOND RXm Research Staining Instruments

LOS ANGELES--(BUSINESS WIRE)--Leica Biosystems and Molecular Instruments partner to bring HCR™ Pro RNA-ISH to BOND RX and RXm, enhancing RNA and protein analysis workflows....
Back to Newsroom